Work

Mo1556: INFLIXIMAB VERSUS ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN’S DISEASE

Year: 2022

Type: conference-abstract

Source: Gastroenterology

DOI: 10.1016/s0016-5085(22)61928-0

Authors: Laura A. Maas, Berkeley N. Limketkai, Mark Lazarev, Joanna Melia, Florin M. Selaru, Alyssa M. Parian

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4283027781

Cites:

Cited by: 1

Related to: 10